• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® CARDIOFORM SEPTAL OCCLUDER; OCCLUDER, TRANSCATHETER SEPTAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® CARDIOFORM SEPTAL OCCLUDER; OCCLUDER, TRANSCATHETER SEPTAL Back to Search Results
Catalog Number GSX0030A
Device Problem Inadequacy of Device Shape and/or Size (1583)
Patient Problem Stroke/CVA (1770)
Event Date 08/24/2017
Event Type  Injury  
Manufacturer Narrative
A review of the manufacturing records verified the lot was processed normally and all pre-release specifications were met.(b)(4).
 
Event Description
It was reported a 30mm gore cardioform septal occluder was implanted on (b)(6) 2017 to close a patent foramen ovale.In (b)(6) 2017, the patient presented with a stroke and follow-up imaging showed two septal shunts.One shunt was behind the aorta and the second shunt was posterior and inferior to the occluder.The second shunt appeared to be a new or previously undetected septal defect.On (b)(6) 2017, a transcatheter reintervention was performed and a 25mm cribriform device was implanted in each shunt with no reported adverse effects to the patient.
 
Manufacturer Narrative
Results: case imaging was received for evaluation.Prior to defect closure, transesophageal echocardiographic images show a multifenestrated defect with an aneurysmal septum.Intracardiac echocardiographic images from the initial procedure ((b)(6) 2017) show no shunts across the implanted gore cardioform septal occluder on color flow doppler, and the occluder is shown splaying around the retro aortic root.Intracardiac echocardiographic images from (b)(6) 2017 show the gore cardioform septal occluder capturing the superior and inferior septal rims; however, a large shunt is seen in the anterior superior portion of the septum.The reported posterior inferior shunt cannot be confirmed by color flow doppler but depictions of a cribriform device on the posterior inferior aspects of the gore cardioform septal occluder confirm an additional defect in that position.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® CARDIOFORM SEPTAL OCCLUDER
Type of Device
OCCLUDER, TRANSCATHETER SEPTAL
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
KENDRICK PEAK MPD B/P
4250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
marci stewart
1500 n. 4th street
flagstaff, AZ 
9285263030
MDR Report Key6852898
MDR Text Key85443517
Report Number2017233-2017-00459
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 09/27/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/08/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/11/2019
Device Catalogue NumberGSX0030A
Device Lot Number15869525
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/11/2017
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age53 YR
Patient Weight86
-
-